|
08 Sep 2011 |
NOVAVAX Announces Publication of Results from H5N1 Influenza Virus-Like Particle Vaccine Phase I/IIa Clinical Trial
|
|
07 Sep 2011 |
ImmunoCellular Therapeutics gives Site Update for Phase II trial of ICT-107
|
|
01 Sep 2011 |
Pevion grants CSL option right to its therapeutic Candida vaccine
|
|
31 Aug 2011 |
Sirona Biochem Develops Cancer Vaccine Antigen
|
|
31 Aug 2011 |
Selecta Biosciences Awarded Subcontract to Develop a Synthetic Nanoparticle Vaccine for Malaria
|
|
29 Aug 2011 |
Positive avian flu trial data using Isconova’s Matrix M published
|
|
26 Aug 2011 |
Results of Emergent BioSolutions Phase 1a Study on Adjuvanted BioThrax Anthrax Vaccine Published in the Journal Vaccine
|
|
25 Aug 2011 |
Bionor Pharma ASA Announces Exploratory Study of Its Lead Therapeutic HIV-Vaccine Candidate Vacc-4x in Combination With Leading Cancer Drug
|
|
24 Aug 2011 |
NanoBio’s Intranasal RSV Vaccine Induces Robust Immunity in Animals
|
|
22 Aug 2011 |
Mayo Clinic Receives FDA Approval for Ovarian and Breast Cancer Vaccines
|
|
22 Aug 2011 |
Isconova and Genocea expand collaboration
|
|
22 Aug 2011 |
Immune Response BioPharma Reports NeuroVax MS Vaccine Increased Results with Women Taking Estrogen
|
|
18 Aug 2011 |
Generex Subsidiary Antigen Express Provides Update on Phase 2 Breast Cancer Immunotherapy Program
|
|
15 Aug 2011 |
Inviragen and University of Texas Medical Branch Receive Funding for Development of a Novel Recombinant Chikungunya Virus Vaccine
|
|
12 Aug 2011 |
Advaxis Completes Pre-IND Meeting for ADXS-PSA
|
|
12 Aug 2011 |
TapImmune to Sponsor Phase 1 Breast Cancer Vaccine Trial Following Recent FDA Approval of Investigational New Drug Application
|
|
12 Aug 2011 |
New Tuberculosis Vaccine Enters Phase IIb Proof-of-Concept Trial in People Living with HIV in Senegal and South Africa
|
|
10 Aug 2011 |
Genesis Biopharma Signs Cooperative Research and Development Agreement With the National Cancer Institute to Develop Cancer Immunotherapies
|
|
05 Aug 2011 |
New Hope for Immune Therapy for Children and Young Adults With Type 1 Diabetes: Founder of Orban Biotech's Landmark Findings for Abatacept Published in The Lancet
|
|
03 Aug 2011 |
International Vaccine Institute and Inviragen Announce a Collaboration to Accelerate Development of a Dengue Vaccine
|
|
03 Aug 2011 |
NanoBio Secures Novel Antigen Source for its Intranasal RSV Vaccine
|
|
03 Aug 2011 |
Merck and Serum Institute Announce Collaboration to Develop and Expand Global Access to Pneumococcal Conjugate Vaccine (PCV)
|
|
01 Aug 2011 |
AbD Serotec and Merck Sign License Agreement for Use of HuCAL GOLD in Vaccine Research
|
|
26 Jul 2011 |
VaxOnco to Sponsor Phase I Trial of a Folate Receptor Alpha-targeted Breast/Ovarian Cancer Therapeutic Vaccine That Recently Received Investigational New Drug Approval From FDA
|
|
21 Jul 2011 |
Vical Reports Successful Nonclinical Results With Vaxfectin(R) Adjuvant
|
